Dendrimer-Enabled Therapeutic Antisense Delivery Systems as Innovation in Medicine.
Sign Up to like & getrecommendations! Published in 2019 at "Bioconjugate chemistry"
DOI: 10.1021/acs.bioconjchem.9b00385
Abstract: Antisense oligonucleotide (AON)-based therapies concern the treatment for genetic disorders or infections such as a range of neurodegenerative and neuromuscular diseases and have shown benefits in animal models and patients. Nevertheless, successes in the clinic… read more here.
Keywords: medicine; antisense delivery; therapeutic antisense; dendrimer enabled ... See more keywords